Scott Snyder has 15 years of experience in CPG consumer insights, category management, merchandising, planning, analytics and finance. Prior to co-founding Geneticure, Scott led Deep Dive by CPG a strategic advisory group for over $10 Billion of consumer categories (including OTC Pharmacy) for Target Corporation in Minneapolis MN. A lifelong and passionate entrepreneur, Scott has a diverse background in Start-Up, Securities, Real Estate, and Biotech/Pharma investing. He has a BA in Business Administration and Marketing Management from the University of St. Thomas, in St. Paul MN.
Dr. Eric Snyder is a Research Scientist and Associate Professor in the College of Education and Human Development at the University of Minnesota, Minneapolis. In his research work, Eric has been a trusted steward of several million dollars in competitive funding from both federal and private sources directed toward advancement of scientific research and human genomics. Dr. Snyder also directs the U of M Clinical Exercise Physiology Laboratory and is actively involved in several pharmacogenetic projects in diseases including heart failure, cystic fibrosis, and type 1 diabetes.
Dr. Ryan Sprissler is the Lead Scientist managing the University of Arizona Genetics Core facility (UAGC) resource laboratory specializing in cutting edge genomic technology. Ryan is a genomics industry pioneer and has leveraged several public/private partnerships fueling the high growth industry of genomic testing. Ryan has over 10 years experience in genetic assay design/testing and is a current member of both the Association for Bioresource Facilities (ABRF) and the Association for Laboratory Automation (ALA) while holding all necessary certifications including BSL2 and GLP.
Dr. Olson is an Associate Professor of Medicine and Consultant in Cardiovascular Diseases at Mayo Clinic. Clinically he works in the Cardiovascular Health Clinic, a preventive and rehabilitative cardiology clinic. He is also the Associate Director of the Energy Balance Core Laboratory in the Clinical Research Unit of the Center for Clinical and Translational Science and Director of the Clinical Integrative Physiology Research Laboratory. His research is focused on mechanisms of functional limitation in chronic cardiopulmonary diseases and is funded by the National Institutes of Health, American Heart Association, and Industry.
Ben Bowman has over 15 years of experience leading companies through all stages of growth and renewal. Ben is especially respected for his ability to apply lean startup methodologies across companies and disparate industries. Before joining Geneticure Ben was the Founding CEO of General Blood, the first of it's kind online marketplace for donated human blood products. Ben has also an extensive background in international manufacturing and supply chain optimization. Ben earned both an undergraduate degree in Entrepreneurship and a MBA from the University of Minnesota's Carlson School of Management.
David is President and CEO of 46 North, LLC, supporting the launch of high growth health care, diagnostics, and wellness initiatives. Prior to launching 46 North in 2015, David spent over 20 years in leadership roles at Mayo Clinic, including Chief Administrative Officer of Mayo Medical Laboratories, providing specialty testing services to over 4,000 hospitals worldwide; Chair of Mayo Clinic Global Business Solutions; and Director of Technology Commercialization at Mayo Medical Ventures. David is an emeritus member of the Mayo Clinic staff and is a board member and treasurer of the national Myotonic Dystrophy Foundation. He received a BA from Stanford University and MBA from St. Thomas University.
Dr. Johnson is a Professor of Medicine and Physiology at Mayo Clinic, Rochester, Minnesota. Dr. Johnson has an established, NIH-funded laboratory to study genetics and cardiorespiratory function in patients with heart failure as well as grants from NSF and DOD focused on environmental physiology. Dr. Johnson Received his BA from Pacific Lutheran University, Masters from St. Cloud State University and PhD in Respiratory Physiology and Biodynamics from the University of Wisconsin, Madison. Dr. Johnson completed through the Mayo Graduate School of Medicine, Mayo Clinic College of Medicine.
Dr. Eisenach is a physician in Denver, Colorado. Formerly an Associate Professor and NIH-funded investigator at Mayo Clinic in Rochester, Minnesota, Dr. Eisenach had a prolific career in studying the effects of genetic variation on cardiovascular control in humans. His formative work on the functional relevance of adrenergic receptor gene variants contributed to the discovery of which genes should be tested in patients with hypertension and other risk factors for cardiovascular disease.